medigraphic.com
ISSN 2007-1523 (Electronic)
Revista Mexicana de Trastornos Alimentarios

2017, Number 2

<< Back Next >>

Revista Mexicana de Trastornos Alimentarios 2017; 8 (2)

Binge eating disorder, depression, anxiety and Agouti gen related neuropeptide in patients with bariatric surgery

Gómez-Alva A, Fernández-Murillo M, Velázquez-Fernández D, Flores-Morales J, León P, Mercado-Celis GE, Betancourt-Ocampo D, Funtanet-Martínez J, Kobi-Lomelin E, Mosti-MMA, Herrera-HMF

Language: Spanish
References: 61
Page: 161-170
PDF size: 692.86 Kb.


ABSTRACT

The objective of this retrospective study was to analyze the relationship between the symptoms of depression, anxiety and binge eating disorder (BED) with the gene related to the Agouti neuropeptide in patients undergoing bariatric surgery. A cohort of 249 adults (average age = 41.1, SD = 11.3), 64.1% women and 35.9% men, were included. The assessment of depression, anxiety and BED symptoms was carried out through a semi-structured interview. In addition, the body mass index was calculated, and blood samples were taken for an allelic discrimination analysis. Of the total number of patients 20.2% were diagnosed with BED, finding an association of this disorder with a lower weight loss after bariatric surgery at 6, 12, 18 and 24 months. The measures of depression and anxiety did not differ between patients with BED vs. without BED. Patients with a mutant allele in the gene related to the Agouti neuropeptide were 2.6 times more likely to present BED (95% CI 1.0-6.8, P = 0.04). In addition, BED appears to be more frequent in patients with a gene related to the Agouti neuropeptide mutated. When obesity is studied, it is emphasized the need to address both psychological and genetic factors.


REFERENCES

  1. American Psychiatric Association. (2000). Diagnostic and statisticalmanual of mental disorders, fourth edition, text revised: DSM-IV-TR. Washington, D. C.: American Psychiatric Association.

  2. American Psychiatric Association. (2014). Manual diagno´ıstico yestadístico de los trastornos mentales: DSM-5. Buenos Aires:Editorial Médica Panamericana.

  3. Amianto, F., Ottone, L., Abbate, G. y Fassino, S. (2015). Binge-eating disorder diagnosis and treatment: A recap in front ofDSM-5. BMC Psychiatry, 15, e-70. http://dx.doi.org/10.1186/s12888-015-0445-6

  4. Azagury, D. E. y Morton, J. M. (2016). Bariatric surgery: Over-view of procedures and outcomes. Endocrinology & MetabolismClinics of North America, 45(3), 647---656. http://dx.doi.org/10.1053/j.gastro.2007.03.057

  5. Barquera, S., Campos-Nonato, I., Hernández-Barrera, L., Pedroza,A. y Rivera-Dommarco, J. A. (2013). Prevalencia de obesidad enadultos mexicanos, 2000-2012. Salud Pública de México, 55(2),151---160.

  6. Berkman, N. D., Brownley, K. A., Peat, C. M., Lohr, K. N., Cullen,K. E., Morgan, L. C., et al. (2015). Management and outco-mes of binge-eating disorder. Agency for Healthcare Researchand Quality. Report No.: 15(16)-EHC030-EF. Disponible en:https://www.ncbi.nlm.nih.gov/pubmed/26764442.

  7. Brethauer, S. A., Kothari, S., Sudan, R., Williams, B., English,W. J., Brengman, M., et al. (2014). Systematic review onreoperative bariatric surgery: American Society for Metabolicand Bariatric Surgery Revision Task Force. Surgery for Obe-sity and Related Diseases, 10(5), 952---972. http://dx.doi.org/10.1016/j.soard.2014.02.014

  8. Buddeberg-Fischer, B., Klaghofer, R., Krug, L., Buddeberg, C.,Müller, M. K., Schoeb, O., et al. (2006). Physical and psycho-social outcome in morbidly obese patients with and withoutbariatric surgery: A 4 1/2-year follow-up. Obesity Surgery, 16(3),321---330. http://dx.doi.org/10.1381/096089206776116471

  9. Bustamante, F., Williams, C., Vega, E. y Prieto, B. (2006). Aspec-tos psiquiátricos relacionados con la cirugía bariátrica. RevistaChilena de Cirugía, 58(6), 481---485. http://dx.doi.org/10.4067/S0718-40262006000600016

  10. Calugi, S., Ruocco, A., El Ghoch, M., Andrea, C., Geccherle,E., Sartori, F., et al. (2016). Residential cognitive-behavioralweight-loss intervention for obesity with and without binge-eating disorder: A prospective case-control study with five-yearfollow-up. International Journal of Eating Disorders, 49(7),723---730. http://dx.doi.org/10.1002/eat.22549

  11. Centro Nacional de Excelencia Tecnológica en Salud. (2012). Diag-nóstico, tratamiento y prevención del sobrepeso y la obesidad exógena: Evidencias y recomendaciones. Disponible en: DOI:10.1002/14651858.CD003641.pub2.

  12. Colquitt, J., Clegg, A., Loveman, E., Royle, P. y Sidhu, M. K.(2005). Surgery for morbid obesity. Cochrane Database Syste-matic Reviews, 4.

  13. Cooper, T. C., Simmons, E. B., Webb, K., Burns, J. L. y Kushner,R. F. (2015). Trends in weight regain following roux-en-Y gas-tric bypass (RYGB) bariatric surgery. Obesity Surgery, 25(8),1474---1481. http://dx.doi.org/10.1007/s11695-014-1560-z

  14. Crowley, N., Lepage, M., Goldman, R., O’Neil, P., Borckardt, J.y Byrne, T. K. (2012). The Food Craving Questionnaire-Trait ina bariatric surgery seeking population and ability to predictpost-surgery weight loss at six months. Eating Behaviors, 13(4),366---370. http://dx.doi.org/10.1016/j.eatbeh.2012.07.003

  15. Cuadro, E. y Baile, J. I. (2015). El trastorno por atracón: Análisisy tratamientos. Revista Mexicana de Trastornos Alimentarios,6(2), 97---107. http://dx.doi.org/10.1016/j.rmta.2015.10.001

  16. Dávila-Torres, J., González-Izquierdo, J. J. y Barrera-Cruz, A.(2015). Panorama de la obesidad en México. Revista Médica delInstituto Mexicano del Seguro Social, 53(2), 240---249.

  17. Errandonea, M. I. (2012). Obesidad y trastornos de alimenta-ción. Revista Médica Clínica Las Condes, 23(2), 165---171.http://dx.doi.org/10.1016/S0716-8640(12)70294-8

  18. Fraser, M., Dhaliwal, C. K., Vickers, M. H., Krechowec, S. O. yBreier, B. H. (2016). Diet-induced obesity and prenatal under-nutrition lead to differential neuroendocrine gene expressionin the hypothalamic arcuate nuclei. Endocrine, 53(3), 839---847.http://dx.doi.org/10.1007/s12020-016-0918-5

  19. Gantz, I. y Fong, T. M. (2003). The melanocortin system. AmericanJournal of Physiology, Endocrinology and Metabolism, 284(3),468---474. http://dx.doi.org/10.1152/ajpendo.00434.2002

  20. García, A. (2014). El trastorno por atracón en el DSM-5. MedicinaPsicosomática y Psiquiatría de Enlace, 110, 70---74.

  21. Gempeler, J. (2005). Trastorno por atracones: ¿Entre los trastornosde la conducta alimenticia y la obesidad? Una mirada cognosci-tiva comportamental. Revista Colombiana de Psiquiatría, 34(2),242---250.

  22. Genetics Home Reference (2016). AGRP gene: Agouti related neuro-peptide. NIH, U. S. National Library of Medicine [consultado 13Jun 2016]. Disponible en: https://ghr.nlm.nih.gov/gene/AGRP

  23. Gerlach, G., Loeber, S. y Herpertz, S. (2016). Personality disor-ders and obesity: A systematic review. Obesity Review, 17(8),691---723. http://dx.doi.org/10.1111/obr.12415

  24. Gill, R. S., Majumdar, S. R., Rueda-Clausen, C. F., Apte, S., Birch,D. W., Karmali, S., et al. (2016). Comparative effectivenessand safety of gastric bypass, sleeve gastrectomy and adjusta-ble gastric banding in a population-based bariatric program:Prospective cohort study. Canadian Journal of Surgery, 59(4),233---241. http://dx.doi.org/10.1503/cjs.013315

  25. Giner, M. (2011). Personalidad y psicopatología en el trastorno poratracón [Tesis doctoral]. Barcelona, Espa˜na: Universidad Inter-nacional de Catalunya. Disponible en: http://www.tdx.cat/bitstream/handle/10803/48513/TESI Montse Giner.pdf;sequence=2

  26. González, E. (2011). Genes y obesidad: Una relación de causa-consecuencia. Endocrinología y Nutrición, 58(9), 492---496.http://dx.doi.org/10.1016/j.endonu.2011.06.004

  27. Haider, D. G., Schindler, K., Prager, G., Bohdjalian, A., Luger, A.,Wolzt, M., et al. (2007). Serum retinol-binding protein 4 isreduced after weight loss in morbidly obese subjects. Journalof Clinical Endocrinology and Metabolism, 92(3), 1168---1171.http://dx.doi.org/10.1210/jc.2006-1839

  28. Hatoum, I. J., Stylopoulos, N., Vanhoose, A. M., Boyd, K. L., Yin,D. P., Ellacott, K. L., et al. (2012). Melanocortin-4 receptorsignaling is required for weight loss after gastric bypass sur-gery. Journal Clinical Endocrinology and Metabolism, 97(6),1023---1031. http://dx.doi.org/10.1210/jc.2011-3432

  29. Herrera, M. (2011). Anatomía fisiología y resultados durante el pri-mer a˜no posterior a la cirugía. En M. F. Herrera y M. Mosti (Eds.),Bypass gástrico: ¿Qué hay más allá de la cirugía? (pp. 1---5).México: Pydesa.

  30. Hood, M. M., Grupski, A. E., Hall, B. J., Ivan, I. y Cor-sica, J. (2013). Factor structure and predictive utility of theBinge Eating Scale in bariatric surgery candidates. SurgeryObesity Related Diseases, 9(6), 942---948. http://dx.doi.org/10.1016/j.soard.2012.06.013

  31. Hudson, J. I., Hiripi, E., Pope, H. G. y Kessler, R. C. (2007). Theprevalence and correlates of eating disorders in the NationalComorbidity Survey replication. Biological Psychiatry, 61(3),348---358. http://dx.doi.org/10.1016/j.soard.2012.06.013

  32. Kalnina, I., Kapa, I., Pirags, V., Ignatovica, V., Schiöth, H. B.y Klovins, J. (2009). Association between a rare SNP in thesecond intron of human Agouti related protein gene and increa-sed BMI. BMC Medical Genetics, 10, 63. http://dx.doi.org/10.1186/1471-2350-10-63

  33. Katsuki, A., Sumida, Y., Gabazza, E. C., Murashima, S., Tanaka, T.,Furuta, M., et al. (2001). Plasma levels of agouti-related proteinare increased in obese men. Journal of Clinical Endocrinologyand Metabolism, 86(5), 1921---1924. http://dx.doi.org/10.1210/jcem.86.5.7458

  34. King, M. W. (2016). Gut-brain interrelationships andcontrol of feeding behavior. Disponible en: http://themedicalbiochemistrypage.org/gut-brain.php

  35. Lépori, L. (2006). Obesidad [Miniatlas]. Buenos Aires: CLYNA.

  36. Luquet, S., Gaudel, C., Holst, D., Lopez-Soriano, J., Jehl-Pietri, C., Fredenrich, A., et al. (2005). Roles of PPARdelta in lipid absorption and metabolism: A new target forthe treatment of type 2 diabetes. Biochimica et BiophysicaActa, 1740(2), 313---317. http://dx.doi.org/10.1016/j.bbadis.2004.11.011

  37. Martínez, J. A. (2004). Determinantes genéticos de la obesidad.Ibérica: Actualidad Tecnológica, 472, 137-139.

  38. McElroy, S. L., Guerdjikova, A. I., Mori, N. y Keck, P. E.(2016). Managing comorbid obesity and depression throughclinical pharmacotherapies. Expert Opinion on Pharma-cotherapy, 17(12), 1599---1610. http://dx.doi.org/10.1080/14656566.2016.1198776

  39. Mestas, L., Gordillo, F., Arana, J. M. y Salvador, J. (2012). Síntesisy nuevas aportaciones para el estudio de la obesidad. RevistaMexicana de Trastornos Alimentarios, 3(2), 99---105.

  40. Mitchell, J. E., King, W. C., Courcoulas, A., Dakin, G., Elder,K., Engel, S., et al. (2015). Eating behavior and eatingdisorders in adults before bariatric surgery. InternationalJournal Eating Disorders, 48(2), 215---222. http://dx.doi.org/10.1002/eat.22275

  41. Núñez-Hernández, V. J., Vargas-Cerero, E. A., Sánchez-Madrigal, J.,Jaramillo, E., Martínez-Navarro, J. y Nava, A. (2014). Nocionessobre fisiología del apetito: Apetito y hambre. Residente, 9(1),15---19.

  42. Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen,Y., Gantz, I., et al. (1997). Antagonism of central mela-nocortin receptors in vitro and in vivo by agouti-relatedprotein. Science, 278(5335), 135---138. http://dx.doi.org/10.1126/science.278.5335.135

  43. Organización Mundial de la Salud. (1998). Obesity: Pre-venting and managing the global epidemic [consultado15 Abr 2015]. Disponible en: http://apps.who.int/iris/handle/10665/42330?locale=es

  44. Organización Mundial de la Salud. (2014). Cifras y datos: 10 datossobre la obesidad [consultado 18 Nov 2016]. Disponible en:http://www.who.int/features/factfiles/obesity/es/

  45. Organización Mundial de la Salud. (2016). Obesidad y sobrepeso[consultado 18 Abr 2015]. Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es/

  46. Organización para la Cooperación y el Desarrollo Económicos.(2014). La obesidad y la economía de la prevención [consul-tado 13 Jul 2015]. Disponible en: https://www.oecd.org/els/health-systems/46068529.pdf

  47. Pawaskar, M., Solo, K., Valant, J., Schmitt, E., Nwankow, M. y Her-man, B. K. (2016). Characterization of binge-eating behavior inindividuals with binge-eating disorder in an adult population inthe United States. Primary Care Companion CNS Disorders, 18(5)http://dx.doi.org/10.4088/PCC.16m01965

  48. Piña, A., Álvarez, I., Madrigal, E. y Espinosa, E. (2011). Revisiónde los principales genes involucrados en el desarrollo de laobesidad. Revista Mexicana de Ciencias Farmacéuticas, 42(4),26---38.

  49. Puziferr, N., Roshek, T. B., Mayo, H. G., Gallagher, R., Belle,S. H. y Livingston, E. H. (2014). Long-term follow-up afterbariatric surgery: A systematic review. Journal of Ameri-can Medical Association, 312(9), 934---942. http://dx.doi.org/10.1001/jama.2014.10706

  50. Ribaric, G., Buchwald, J. N. y McGlennon, T. W. (2014).Diabetes and weight in comparative studies of baria-tric surgery vs conventional medical therapy: A systematicreview and meta-analysis. Obesity Surgery, 24(3), 437---455.http://dx.doi.org/10.1007/s11695-013-1160-3

  51. Rivera, J. A., Campos-Nonato, I., Barquera, S. y González, T. (2013).Epidemiología de la obesidad en México: Magnitud, distribución,tendencias y factores de riesgo. En J. A. Rivera, M. Hernán-dez, C. A. Aguilar, F. Vadillo, y C. Murayama (Eds.), Obesidaden México: Recomendaciones para una política de Estado (pp.92---118). México: Universidad Nacional Autónoma de México,Academia Nacional de Medicina, Academia Mexicana de Cirugía,Academia Mexicana de Pediatría e Instituto Nacional de SaludPública.

  52. Sarwer, D. B. y Dilks, R. (2011). Overview of the psychological andbehavioral aspects of bariatric surgery. Bariatric Times, 8(2),18---24.

  53. Shutter, J. R., Graham, M., Kinsey, A. C., Scully, S., Lüthy, R. yStark, K. L. (1997). Hypothalamic expression of ART, a novelgene related to agouti, is up-regulated in obese and dia-betic mutant mice. Genes & Development, 11(5), 593---602.http://dx.doi.org/10.1101/gad.11.5.593S

  54. jöström, L. (2013). Review of the key results from the SwedishObese Subjects (SOS) trial: A prospective controlled interventionstudy of bariatric surgery. Journal of Internal Medicine, 273(3),219---234. http://dx.doi.org/10.1111/joim.12012

  55. Utzinger, L. M., Gowey, M. A., Zeller, M., Jenkins, T. M., Engel,S. G., Rofey, D. L., et al. (2016). Loss of control eatingand eating disorders in adolescents before bariatric surgery.International Journal of Eating Disorders, 49(10), 947---952.http://dx.doi.org/10.1002/eat.22546

  56. Vásquez-Machado, M. y Ulate-Montero, G. (2010). Regulación delpeso corporal y del apetito. Acta Médica Costarricense, 52(2),79---89.

  57. Vázquez, R., López, X., Ocampo, M. T. y Mancilla-Diaz, J. M.(2015). El diagnóstico de los trastornos alimentarios del DSM-IV-TR al DSM-5. Revista Mexicana de Trastornos Alimentarios, 6,108---120. http://dx.doi.org/10.1016/j.rmta.2015.10.003

  58. Velázquez-Fernández, D., Mercado-Celis, G., Flores-Morales, J.,Clavellina-Gaytán, D., Vidrio, R., Vidrio, E., et al. (2016). Analy-sis of gene candidate SNP and ancestral origin associated toobesity and postoperative weight loss in a cohort of obesepatients undergoing RYGB. Obesity Surgery., 27(6), 1481---1492.http://dx.doi.org/10.1007/s11695-016-2501-9

  59. Wadden, T. A., Faulconbridge, L. F., Jones-Corneille, L. R., Sarwer,D. B., Fabricatore, A. N., Thomas, J. G., et al. (2011). Bingeeating disorder and the outcome of bariatric surgery at one year:A prospective, observational study. Obesity, 19(6), 1220---1228.http://dx.doi.org/10.1038/oby.2010.336

  60. Wimmelmann, C. L., Dela, F. y Mortensen, E. L. (2014). Psy-chological predictors of mental health and health-relatedquality of life after bariatric surgery: A review of the recentresearch. Obesity Research & Clinical Practice, 8(4), 314---324.http://dx.doi.org/10.1016/j.orcp.2013.09.003

  61. Wright, W. (2000). Así nacemos: Genes, conducta, personalidad.Madrid: Taurus.




2020     |     www.medigraphic.com